Buy MYnd Analytics Stock | MYND Stock Price & Latest News | Public
MYND

MYnd Analytics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About MYND

    Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in To...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$60,1M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$2.80
    1 Year Low$0.70
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app